AbbVie (ABBV) Net Margin (2012 - 2026)

AbbVie (ABBV) has reported Net Margin for 15 consecutive years, with 21.28% the latest figure, recorded in Q2 2026.

• On a quarterly basis, Net Margin rose 1518.0% year-over-year to 21.28% in Q2 2026; TTM through Jun 2026 was 9.81%, a 334.0% increase from a year earlier, with the FY2025 full-year figure at 6.92%, down 69.0% from the prior year.
• Net Margin was 21.28% for Q2 2026 at AbbVie, up from 4.65% in the prior quarter.
• Over five years, Net Margin peaked at 33.19% in Q1 2022 and troughed at 0.79% in Q1 2023.
• A 5-year average of 11.11% and a median of 10.24% in 2025 frame the typical range for Net Margin.
• Across the five-year window, Net Margin sank 3398 bps in 2023 and surged 1518 bps in 2026, its largest moves.
• Over 5 years, Net Margin stood at 16.35% in 2022, then slumped by 65 bps to 5.76% in 2023, then plunged by 103 bps to 0.15% in 2024, then soared by 7271 bps to 10.92% in 2025, then jumped by 95 bps to 21.28% in 2026.
• The last three Net Margin figures came in at 21.28% (Q2 2026), 4.65% (Q1 2026), and 10.92% (Q4 2025), per Business Quant data.